Sensei Biotherapeutics, Inc. (SNSE)
31.56
+1.01
(+3.31%)
USD |
NASDAQ |
Mar 20, 16:00
31.27
-0.29
(-0.92%)
Pre-Market: 20:00
Sensei Biotherapeutics Research and Development Expense (Quarterly) : 2.533M for June 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 4.268B |
| Tactile Systems Technology, Inc. | 2.531M |
| Eton Pharmaceuticals, Inc. | 1.78M |
| Vir Biotechnology, Inc. | 85.53M |
| Tango Therapeutics, Inc. | 31.62M |